The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion
Publishing timestamp: 2023-01-31 13:41:53
Summary
Pfizer reported record revenue of $100 billion in 2022, driven by its Covid vaccine and antiviral pill Paxlovid. However, Pfizer expects revenue to decline in 2023 by as much as 33% due to the world emerging from the pandemic and demand for its blockbuster Covid drugs slowing. CEO Albert Bourla has laid out a 2030 growth plan for the company that looks beyond the pandemic.
Sentiment: NEUTRAL
Tickers: PFE,
Keywords: biotechnology, pharmaceuticals, pandemics, epidemics, coronavirus, earnings reports, vaccinations, disease outbreaks, business, pfizer inc, u.s. economy, breaking news: business, health care industry, biotech and pharmaceuticals, politics, covid-19, business news,